Retatrutide, developed by Soma, represents a exciting breakthrough in weight control . This innovative medication combines hormonal receptor agonist function with GIP pathway engagement, indicating impressive results in trial studies for weight improvement. Scientists believe Retatrutide could provide a alternative pathway for patients experiencing